Results 221 to 230 of about 192,309 (409)

Warfarin and Distalgesic interaction. [PDF]

, 1976
M. Orme, A Breckenridge, PS Cook
openalex   +1 more source

Warfarin brands [PDF]

Australian Prescriber, 2015
Linda Graudins, Fiona Chen, Ingrid Hopper, Philip A Tideman, Rosy Tirimacco, Andrew St John, Gregory W Roberts   +6 more
openaire   +2 more sources

Collaborative Study of a Semiautomated Method for the Analysis of Acenocoumarol, Phenprocoumon, and Potassium Warfarin Tablets [PDF]

, 1975
Richard E. Kolinski
openalex   +1 more source

Splenic Infarction After Sclerotherapy for Gastric Varices due to Anatomical Variation of Left Gastric Artery: A Case Report and Literature Review

Journal of Digestive Diseases, EarlyView.
Shuai Jie Qian, Zhi Yin Huang, Yang Tai, Cheng Wei Tang, Hao Wu   +4 more
wiley   +1 more source

Association between Cytochrome P450 2 C9 and Vitamin K Epoxide Reductase Complex Subunit 1 Polymorphisms with Warfarin dose among Iranian Patients

Research in Molecular Medicine, 2016
Background: Warfarin is a common anticoagulant drug that has a narrow therapeutic index; higher dose causes excessive bleeding and lower dose leads to cerebrovascular clotting and stroke in patients.
Reyhaneh Kameli, Mandana Hasanzad, Zahra Tahmasebi Fard, Mojgan Babanejad, Mahdieh Imeni, Lotfollah Feizi Barnaji, Atoosa Madadkar, Seyed Hamid Jamaldini   +7 more
doaj  

Interaction between azapropazone and warfarin. [PDF]

, 1977
P R Powell-Jackson
openalex   +1 more source

Pathogenic variants in chromatin‐related genes: Linking immune dysregulation to neuroregression and acute neuropsychiatric disorders

Developmental Medicine &Child Neurology, EarlyView.
Chromatin machinery influences how DNA is ‘wrapped’ around histones in the nucleosome of immune and brain cells. Plain language summary: https://onlinelibrary.wiley.com/doi/10.1111/dmcn.16299 Abstract We report eight children with de novo pathogenic DNA variants in chromatin‐related genes: MORC2, CHD7, KANSL1, KMT2D, ZMYND11, HIST1HIE, EP300, and KMT2B.
Russell C. Dale, Shekeeb Mohammad, Velda X. Han, Hiroya Nishida, Himanshu Goel, Stuart G. Tangye, Georgina Hollway, Esther Tantsis, Deepak Gill, Shrujna Patel, Chromatin Immune‐Brain Group, Michael Lonergan, Melanie Wong, Kavitha Kothur, Erica Tsang   +14 more
wiley   +1 more source

Chondrodysplasia punctata and maternal warfarin treatment. [PDF]

, 1977
Alistair Abbott, J R Sibert, Judith B. Weaver   +2 more
openalex   +1 more source

Dicoumarol and warfarin [PDF]

Heart, 1991
openaire   +2 more sources

Apixaban in patients with nonvalvular atrial fibrillation, heart failure and low body weight: A report from a global federated research dataset

European Journal of Clinical Investigation, EarlyView.
In a cohort of 155,152 patients with atrial fibrillation, heart failure and low body weight, patients weighting <60 kg faced a higher risk of adverse events compared to those in the reference BW (60–100 kg), regardless of treatment. Apixaban demonstrated a lower risk of ischaemic stroke/systemic embolism, bleedings (including intracranial hemorrhage ...
Luca Monzo, Guillaume Baudry, Gema Hernandez, Olivier Denquin, Gianluigi Savarese, Gregory Y. H. Lip, Nicolas Girerd   +6 more
wiley   +1 more source